@article{50e954fc6ac34416b7abb3a1754b37e5,
title = "Are traditional approaches diminishing the bipolar drug pipeline?",
keywords = "Bipolar disorder, bipolar inventory symptom scale (BISS), multi-state outcome analysis of treatment (MOAT), symptom domains",
author = "Charles Bowden and Melissa Martinez",
note = "Funding Information: C Bowden is a Scientific Director for Biomedical Development Corp. and C Bowden has received funding from the National Institute of Mental Health via grants 5P30MH086045, 2/R24MH091997 and STTR/R24MH091997 (subcontracted with the Biomedical Development Corp). He has also received funding from Myriad Genetics Inc. M Martinez has received funding from Myriad Genetics Inc as well as well from the National Institute of Mental Health via grants STTR/R24MH091997 (subcontracted with the Biomedical Development Corp) and 5P30MH086045. She has also received funding from Methodist Healthcare Ministries via the South Texas Access to Recovery grant.",
year = "2018",
month = apr,
day = "13",
doi = "10.1080/14656566.2018.1454429",
language = "English (US)",
volume = "19",
pages = "525--528",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Taylor and Francis Ltd.",
number = "6",
}